Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack C Sipe

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Review of Neurotherapeutics|March 2, 2010
Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosisJack C Sipe
Expert Review of Neurotherapeutics|November 9, 2005
Cladribine for multiple sclerosis: review and current statusJack C Sipe
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|October 17, 2008
Cladribine tablets' potential in multiple: sclerosis treatmentKathleen Costello, Jack C Sipe
Developmental Neuroscience|October 29, 2002
Brain iron metabolism and neurodegenerative disordersJack C Sipe, Pauline Lee, Ernest Beutler
Science (New York, N.Y.)|February 10, 1978
Health: whose responsibility?Anselm L Strauss, Jack C Sipe, John H Knowles
Journal of Leukocyte Biology|April 23, 2005
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disordersJack C Sipe, Nathalie Arbour, Alexandra Gerber, et al.
Human Molecular Genetics|July 16, 2004
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug useKyle P Chiang, Alexandra L Gerber, Jack C Sipe, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 10, 2007
The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in CaucasiansRachel F Tyndale, Jennifer I Payne, Alexandra L Gerber, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
A missense mutation in human fatty acid amide hydrolase associated with problem drug useJack C Sipe, Kyle Chiang, Alexandra L Gerber, et al.
Human Genetics|September 15, 2006
The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addictionJonathan M Flanagan, Alexandra L Gerber, Jean Lud Cadet, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Review of Neurotherapeutics|March 2, 2010
Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosisJack C Sipe
Expert Review of Neurotherapeutics|November 9, 2005
Cladribine for multiple sclerosis: review and current statusJack C Sipe
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|October 17, 2008
Cladribine tablets' potential in multiple: sclerosis treatmentKathleen Costello, Jack C Sipe
Developmental Neuroscience|October 29, 2002
Brain iron metabolism and neurodegenerative disordersJack C Sipe, Pauline Lee, Ernest Beutler
Science (New York, N.Y.)|February 10, 1978
Health: whose responsibility?Anselm L Strauss, Jack C Sipe, John H Knowles
Journal of Leukocyte Biology|April 23, 2005
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disordersJack C Sipe, Nathalie Arbour, Alexandra Gerber, et al.
Human Molecular Genetics|July 16, 2004
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug useKyle P Chiang, Alexandra L Gerber, Jack C Sipe, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 10, 2007
The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in CaucasiansRachel F Tyndale, Jennifer I Payne, Alexandra L Gerber, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
A missense mutation in human fatty acid amide hydrolase associated with problem drug useJack C Sipe, Kyle Chiang, Alexandra L Gerber, et al.
Human Genetics|September 15, 2006
The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addictionJonathan M Flanagan, Alexandra L Gerber, Jean Lud Cadet, et al.
Pageof 2